Researchers at Western University have developed a new way to deliver the DNA-editing tool CRISPR-Cas9 into microorganisms in the lab, providing a way to efficiently launch a targeted attack on specific bacteria.
Published today in Nature Communications, this study opens up the possibility of using CRISPR to alter the makeup of the human microbiome in a way that could be personalized and specific from person to person. It also presents a potential alternative to traditional antibiotics to kill bacteria like Staphyloccous aureus (Staph A) or Escherichia coli (E. coli).
“One of the major reasons that I am excited about this work is that it has a wide range of possible real-world applications,” said Bogumil Karas, PhD, Assistant Professor at Western’s Schulich School of Medicine & Dentistry. “It has the potential for development of next generation antimicrobial agents that would be effective even for bacteria that are resistant to all known antibiotics. This technology could also be used to help ‘good’ bacteria produce compounds to treat diseases caused by protein deficiencies.”
CRISPR stands for Clustered Regularly Interspaced Short Palindromic Repeats and can be programmed to target specific stretches of genetic code and to edit DNA at precise locations. Researchers use CRISPR to permanently modify genes in living cells and organisms.
In this way, CRISPR can be programmed to kill bacteria, but until now there wasn’t a way to efficiently and specifically target certain bacterial strains.
“Using CRISPR to kill things isn’t a new idea because that’s what CRISPR does naturally,” said David Edgell, PhD, Professor at Schulich Medicine & Dentistry. “The problem has always been how you get CRISPR to where you want it to go. Other delivery systems could only go to a few spots, where ours can go anywhere.”
The delivery system developed at Western uses bacteria’s natural ability to replicate – called bacterial conjugation – to deliver CRISPR to specific bacteria, in order to alter its DNA and kill it.
“Specific delivery of any therapeutic agent, including CRISPR, is usually one of the biggest bottlenecks in development of new treatments. By developing this new delivery system, we created new tools that could help us in the development of more effective therapies in the near future,” said Karas.
The team says their delivery system is not only broadly applicable, but it is also more efficient than previous systems.
“We were able to show near complete transfer of the delivery vehicle to another bacterial species under conditions where they are in intimate contact – in a biofilm. This is important because biofilms are the natural state of the majority of bacteria, and being able to transfer DNA under these conditions is typically difficult, but we found a way to make it easy and efficient,” said Gregory Gloor, PhD, Professor at Schulich Medicine & Dentistry.
Learn more: Researchers unlock potential to use CRISPR to alter the microbiome
The Latest on: Next generation antimicrobial agents
[google_news title=”” keyword=”next generation antimicrobial agents” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Next generation antimicrobial agents
- Matinas BioPharma Holdings, Inc. (AMEX:MTNB) Q1 2024 Earnings Call Transcripton May 10, 2024 at 9:46 am
Q1 2024 Earnings Call Transcript May 9, 2024 Matinas BioPharma Holdings, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator ...
- New plan to tackle antimicrobial resistance launchedon May 7, 2024 at 9:37 pm
A new plan to tackle antimicrobial resistance (AMR), a global issue that makes infections difficult or impossible to treat, has been launched today.
- WOAH report shows rise in antimicrobial use in animalson May 7, 2024 at 1:43 pm
WOAH has been monitoring the use of antimicrobials in food-producing animals since 2015 as part of its efforts to limit the emergence of drug-resistant bacteria. Overuse of medically important ...
- BARDA announces first next-generation countermeasure accelerator hubson May 7, 2024 at 12:56 pm
The Biomedical Advanced Research and Development Authority (BARDA), part of the US Department of Health and Human Services (HHS), yesterday announced the first two hubs in its next- generation BARDA ...
- In Vivo Efficacy of Matinas BioPharma’s Oral MAT2203 in Pulmonary Mucormycosis Published in Journal of Antimicrobial Agents and Chemotherapyon April 30, 2024 at 5:45 am
Matinas BioPharma Holdings, Inc. (NYSE American: MTNB), a clinical-stage biopharmaceutical company focused on delivering groundbreaking therapies using its lipid nanocrystal (LNC) platform delivery ...
- Antimicrobial agents of the futureon April 25, 2024 at 8:04 am
HIRI researchers conducted the first systematic study of CRISPR-based antibiotics in Klebsiella pneumonia The antimicrobial ... ventured into the next stage of active agent development, namely ...
- Researchers systematically investigate efficacy of CRISPR antimicrobial agentson April 24, 2024 at 5:00 pm
The antimicrobial potential of CRISPR-Cas ... The team also ventured into the next stage of active agent development, namely delivery. The researchers used bacteriophages as vehicles for the ...
- Functional Gold Nanoclusters as Antimicrobial Agents for Antibiotic-resistant Bacteriaon March 30, 2024 at 5:01 pm
Aims: Our aim was to demonstrate that lysozyme-directed generation of gold nanoclusters (Au NCs) are potential antimicrobial agents for antibiotic-resistant bacteria and broad labeling agents for ...
- Next-generation sequencing: in summaryon October 22, 2021 at 8:51 pm
What is next-generation sequencing? Next-generation sequencing (often noted as NGS), describes the high-throughput technologies that can now determine the sequence of a given nucleic acid strand, such ...
- BioVersys: saving lives in resistant timeson October 18, 2021 at 5:24 am
The Swiss pharmaceutical company BioVersys is developing next-generation antimicrobial drugs with ... is already known to be a fast bactericidal agent, distributing well into lungs, and safe ...
via Bing News